Unique ID issued by UMIN | UMIN000020468 |
---|---|
Receipt number | R000023637 |
Scientific Title | Establishment and analyses of induced pluripotent stem (iPS) cells / human-induced neuronal (hiN) cells / induced microglia-like (iMG) cells from tissue, to elucidate the pathogenesis and pathophysiology of mental and developmental disorders. |
Date of disclosure of the study information | 2016/01/07 |
Last modified on | 2025/03/11 18:28:49 |
Establishment and analyses of induced pluripotent stem (iPS) cells / human-induced neuronal (hiN) cells / induced microglia-like (iMG) cells from tissue, to elucidate the pathogenesis and pathophysiology of mental and developmental disorders.
Establishment and analyses of induced pluripotent stem (iPS) cells / human-induced neuronal (hiN) cells / induced microglia-like (iMG) cells from tissue, to elucidate the pathogenesis and pathophysiology of mental and developmental disorders.
Establishment and analyses of induced pluripotent stem (iPS) cells / human-induced neuronal (hiN) cells / induced microglia-like (iMG) cells from tissue, to elucidate the pathogenesis and pathophysiology of mental and developmental disorders.
Establishment and analyses of induced pluripotent stem (iPS) cells / human-induced neuronal (hiN) cells / induced microglia-like (iMG) cells from tissue, to elucidate the pathogenesis and pathophysiology of mental and developmental disorders.
Japan |
Multifactorial psychiatric disorders including schizophrenia, depression, bipolar disorders, neurocognitive disorders, eating disorders, anxiety disorders, sleep disorders and autism spectrum disorders
Psychiatry |
Others
YES
This study aims to establish iPS cells from patients with psychiatric disorders, differentiate them into such as neuronal cells and brain tissues, and identify disease mechanisms while developing a drug evaluation system. Additionally, we will induce and analyze blood vessels, blood cells, the gut, macrophages, and the heart, which are linked to psychiatric disorders and potential comorbidities. Through these efforts, we seek a comprehensive understanding of psychiatric disease pathophysiology.
Others
analysis of pathophysiology
None
Observational
0 | years-old | <= |
120 | years-old | >= |
Male and Female
Patients with psychiatric disorders (schizophrenia, depression, bipolar disorders, substancerelated disorders, neurocognitive disorders, eating disorders, anxiety disorders, sleep disorders, autism spectrum disorders et al.) and psychiatrically normal controls
None
30
1st name | |
Middle name | |
Last name | Norio Ozaki |
Nagoya University, Graduate School of Medicine
Department of psychiatry
Showaku, Tsurumai-cho 65, Nagoya
052-744-2282
ozaki-n@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Yuko Arioka |
Nagoya University, Graduate School of Medicine
Department of psychiatry
Showaku, Tsurumai-cho 65, Nagoya
052-744-2282
ariokay@med.nagoya-u.ac.jp
Department of Psychiatry, Nagoya University, Graduate School of Medicine
Ministry of Education, Culture, Sports, Science and Technology of Japan, AMED
Japanese Governmental office
NO
2016 | Year | 01 | Month | 07 | Day |
Unpublished
Enrolling by invitation
2012 | Year | 10 | Month | 17 | Day |
2025 | Year | 02 | Month | 07 | Day |
2012 | Year | 10 | Month | 17 | Day |
2027 | Year | 03 | Month | 31 | Day |
Case-control study.
Study subjects: patients meeting diagnositic criteria for psychiatric disorders (recruited at Nagoya university hospital and its related hospitals) and psychiatrically normal controls.
2016 | Year | 01 | Month | 07 | Day |
2025 | Year | 03 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023637